首页> 外文会议>World Congress on Heart Disease. >Matrix Metalloproteases, Chitotriosidase, and Cystatin C in a long-term study in patients after cardiosurgery
【24h】

Matrix Metalloproteases, Chitotriosidase, and Cystatin C in a long-term study in patients after cardiosurgery

机译:基质金属蛋白酶,核苷酸化酶和胱抑素C在表皮前期患者的长期研究中

获取原文

摘要

Potent non-lipid markers of atherosclerosis - matrix metalloproteases (MMP), chitotriosidase and cystatin C - were assayed in long-term (1, 2 and 3 years) study of patients after coronary bypass surgery. Patients with prior ischemic heart disease (IHD) had demonstrated significantly elevated levels of CRP-hs, total cholesterol and TG, cystatin C, MMP and chitotriosidase activity. Following surgery there was a tendency for a decrease in CRP-hs and serum lipids (at 1 and 2 years after the operation, especially in the statin-treated group), however, all indexes studied were still elevated vs the control group of low IHD risk. The hypolipidemic effect of simvastatin in IHD patients was shown to correlate with decreased CRP-hs level and MMP activity, associated with the pleiotropic effect of statins.
机译:动脉粥样硬化 - 基质金属蛋白酶(MMP),际千核苷酸酶和胱抑素C-的有效的非脂质标志物在冠状动脉旁路手术后的长期(1,2和3岁)研究中测定患者的长期(1,2和3岁)。患有先前缺血性心脏病(IHD)的患者表现出显着升高的CRP-HS,总胆固醇和TG,胱抑素C,MMP和障碍前导酶活性。手术后,CRP-HS和血清脂质的趋势(在手术后1和2年,特别是在他汀类药物治疗组),然而,研究的所有指标仍升高,对照组低IHD风险。辛伐他汀在IHD患者中的低血散效应显示与司汀类药物的抗性效应有关的CRP-HS水平和MMP活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号